Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2024 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Virological characteristics of the SARS-CoV-2 JN.1 variant.
Lancet Infect Dis. 2024 Feb;24(2):e82. doi: 10.1016/S1473-3099(23)00813-7. Epub 2024 Jan 3.
Lancet Infect Dis. 2024.
PMID: 38184005
No abstract available.
Real-Time Survey of Vaccine Safety of the mRNA-1273 SARS-CoV-2 Vaccine in Workplace Vaccination at Keio University.
Okumura K, Hara A, Inada I, Sugiyama D, Hoshino T, Yakoh T, Yokoyama H, Urushihara H.
Okumura K, et al.
Vaccines (Basel). 2022 Sep 3;10(9):1461. doi: 10.3390/vaccines10091461.
Vaccines (Basel). 2022.
PMID: 36146539
Free PMC article.
Item in Clipboard
Virological characteristics of the SARS-CoV-2 KP.2 variant.
Kaku Y, Uriu K, Kosugi Y, Okumura K, Yamasoba D, Uwamino Y, Kuramochi J, Sadamasu K, Yoshimura K, Asakura H, Nagashima M; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K.
Kaku Y, et al. Among authors: okumura k.
Lancet Infect Dis. 2024 May 20:S1473-3099(24)00298-6. doi: 10.1016/S1473-3099(24)00298-6. Online ahead of print.
Lancet Infect Dis. 2024.
PMID: 38782005
No abstract available.
Item in Clipboard
Cite
Cite